CognitiveMeta-analysis
Cerebrolysin: what the stroke and dementia trials show once you add them up
Manufacturer-backed trials and pooled analyses report benefits; independent Cochrane reviews find no effect on stroke deaths and only very low-certainty gains in dementia.
